Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-032091

See Remarks sold 2,485 shares at an average $3.04 ($7,561)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schwartz Jonathan David See Remarks 2025-08-18 Sale −1,680 $3.07 $5,149 222,414 D: show line 1 in the form
Schwartz Jonathan David See Remarks 2025-08-19 Sale −805 $3.00 $2,412 221,609 D: show line 2 in the form
Open-market sales · 2,485 sh · avg $3.04 · $7,561
Loading xslF345X05/form4.xml…